LENZ$3.55+16.33%
LENZ Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$111.48M
Float & O/S:
Inst Own:
DilutionScan read 38 of LENZ Therapeutics, Inc.'s SEC filings and found 1 warrant series, 1 ATM program, 4 shelf registrations and 2 S-1 registrations on file for LENZ. The latest dilution event on file is ATM sales on Dec 31, 2025. Analysis updated Oct 31, 2026.